Devazepide

Devazepide (L-364,718, MK-329) is benzodiazepine drug, but with quite different actions from most benzodiazepines, lacking affinity for GABA_A receptors and instead acting as an CCK_A receptor antagonist. It increases appetite and accelerates gastric emptying, and has been suggested as a potential treatment for a variety of gastrointestinal problems including dyspepsia, gastroparesis and gastric reflux. It is also widely used in scientific research into the CCK_A receptor.

Synthesis

Devazepide is synthesised in a similar manner to other benzodiazepines.

References

↑ US Patent 4820834

↑ Hill DR, Woodruff GN. Differentiation of central cholecystokinin receptor binding sites using the non-peptide antagonists MK-329 and L-365,260. Brain Research. 1990 Sep 3;526(2):276-83. PMID 2257485

↑ Cooper SJ, Dourish CT. Multiple cholecystokinin (CCK) receptors and CCK-monoamine interactions are instrumental in the control of feeding. Physiology and Behaviour. 1990 Dec;48(6):849-57. PMID 1982361

This page contains text from Wikipedia, the Free Encyclopedia - https://wn.com/Devazepide

Podcasts:

Email this Page Play all in Full Screen Show More Related Videos

back

Most Related
Most Recent
Most Popular
Top Rated

expand screen to full width
repeat playlist
shuffle
replay video
clear playlist restore
images list

PLAYLIST TIME:

Devazepide

Synthesis

See also

References

Podcasts:

EXPLORE WN.com